Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|October 16, 2021
Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing WorldDouglas McNair, Murray Lumpkin, Steven Kern, et al.NPJ Vaccines|October 28, 2020
Navigating facilitated regulatory pathways during a disease X pandemicShmona Simpson, Ajoy Chakrabarti, David Robinson, et al.Plos One|November 17, 2016
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market AuthorizationVincent Ahonkhai, Samuel F Martins, Alexandre Portet, et al.Journal of Public Health Policy|March 11, 2016
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authoritiesLawrence Liberti, Alasdair Breckenridge, Jarno Hoekman, et al.Journal of Pharmaceutical Policy and Practice|July 1, 2020
Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'Tamara Hafner, Marlon Banda, Jillian Kohler, et al.Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.PLOS Global Public Health|June 3, 2026
Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equityJean Christophe Rusatira, Eishita Pal, Jean Berchmans Uwimana, et al.Plos Medicine|August 14, 2020
Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiativeHiiti Sillo, Aggrey Ambali, Samvel Azatyan, et al.Globalization and Health|November 2, 2018
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systemsLukas Roth, Daniel Bempong, Joseph B Babigumira, et al.Clinical Pharmacology and Therapeutics|November 26, 2018
Recognizing that Evidence is Made, not BornRobyn Lim, David K Lee, Pierre Sabourin, et al.Pageof 2